CTI BioPharma Corp (fka CTIC)

[Frankestin]

https://seekingalpha.com/article/4476763-cti-biopharma-long-and-troubled-history-finally-approaching-approval#comments

I find this comment interesting

I am a hematologist at an academic medical center and recently attended(virtually) the Annual Meeting of the American Society of Hematology which took place in Atlanta. I am pleased to report that's the safety issues voiced by Avisol Partners were very well addressed by abstract 3640(Safety Analysis of Pacritinib in Patients with Myelofibrosis and Severe Thrombocytopenia) and abstract 3639( A retrospective Head to head comparison between Pacritinib and Ruxilotinib in patients with Myelofibrosis and moderate to Severe Thrombocytopenia). There are three additional abstracts supportive of the value of pacritinib. The five abstracts are from 15 different major medical centers both in the US and EU, and are co-authored by 25 different hematologists including key opinion leaders in the field of myeloproliferative diseases(the abstracts are available on the company website). During the Meeting several key opinion leaders said they were eagerly awaiting the availability of the drug to treat their patients with severe thrombocytopenia. I am optimistic that pacritinib will be approved by the FDA on February 28, if not sooner. The recent rapid recovery of the share price is consistent with an approval in the near future.